Recently, there is an increase in the incidence of thrombotic events in children requiring treatment or prophylaxis with new oral anticoagulants (NOACs). Currently, there is insufficient evidence on the use of NOACs in children.
Recently, there is an increase in the incidence of thrombotic events in children requiring treatment or prophylaxis with new oral anticoagulants (NOACs). Currently, there is insufficient evidence on the use of NOACs in children.